Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10882029 | Cell Biology International | 2005 | 7 Pages |
Abstract
The results indicate that the brain lipid levels in the DÂ +Â VELAVC, diabetes 1 and diabetes 2 groups were higher than in the control group (PÂ <Â 0.01). Total lipid was also higher in the non-diabetic rats treated with LA and VC. Total cholesterol was higher in the diabetes 1 and diabetes 2 groups (PÂ <Â 0.05) than in controls. Cholesterol levels were similar in the DÂ +Â VELAVC and LA groups but lower in the VC, VE and VELAVC groups of non-diabetic rats (PÂ <Â 0.05 and PÂ <Â 0.01). In respect of fatty acid composition, palmitic acid levels were lower in the diabetes 2 and non-diabetic VE groups than the control group (PÂ <Â 0.05), but higher in the non-diabetic LA group (PÂ <Â 0.05). Oleic acid (18:1 n-9) levels were lower in the diabetic and non-diabetic groups than the control group (PÂ <Â 0.01), but higher in the non-diabetic LA group. Arachidonic acid (20:4 n-6) levels were similar in the diabetes 1, DÂ +Â VELAVC and control groups (PÂ >Â 0.05) but higher in the non-diabetic VE, VC, LA and VEVCLA groups (PÂ <Â 0.05) and lower in the diabetes 2 group (PÂ <Â 0.05). Docosahexaenoic acid (22:6 n-3) was elevated in the diabetes 2 and VEVCLA groups (PÂ <Â 0.01, PÂ <Â 0.05). In conclusion, the current study confirmed that treatment with a triple combination of VE, VC and LA protects the arachidonic acid level in the brains of diabetic and non-diabetic rats.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biophysics
Authors
Yusuf Ãzkan, ÃkkeÅ Yilmaz, Ali Ä°hsan Ãztürk, Yasemin ErÅan,